http://www.chicagotribune.com/technology/local/chi-0604110267apr11,1,7715921.story?coll=chi-technologylocal-hed

Scientists become trading card heroes

By Jon Van
Chicago Tribune staff reporter

April 11, 2006


In an unusual twist, trading cards that feature scientists instead of 
athletes were launched Monday at the BIO2006 trade show at McCormick Place.

"Collect 'em now and get an autograph," said Jack Lavin, director of the 
Illinois Department of Commerce. "They'll be worth thousands once they win 
a Nobel!"

The cards are just one clue to the true nature of biotechnology: It's the 
intersection of serious science and unbridled marketing.

In a meeting at which up to 20,000 people from around the world are 
gathering, it seems that everyone has a gimmick to call attention to their 
message.

Lavin said the Illinois biotech trade association developed the trading 
cards to call attention to the plentiful supply of smart researchers 
working at universities in Illinois and other Midwestern states.

Illinois' promotion of its biotech capabilities has two goals, said Lavin: 
The state would like foreign companies to consider Illinois as a good base 
for their U.S. operations, and state officials want to attract more 
investors who will put money into local start-up companies. He cited the 
Japanese pharmaceutical firm Takeda, which located its North American 
facility in Lincolnshire.

"They benefit the state by employing hundreds of people in high-tech jobs 
that pay well above average," Lavin said. "They also use services of 
lawyers, accountants and others located here. By bringing thousands of 
people from other countries to Chicago, BIO gives us the opportunity to 
convince other companies like Takeda that this is a great base for their 
operations."

Lavin said about 60,000 Illinois jobs are related to biotechnology. That's 
a substantial number, but the general perception is that the East Coast and 
West Coast are where most of the action is.

"For a lot of people the Midwest is just a flyover between the coasts," 
said Robert Rosenberg, University of Chicago research assistant vice 
president. "This meeting attracted 30 percent more visitors from other 
countries than any previous BIO meeting, and we wanted to call attention to 
all the great researchers working here."

One of the featured scientists is Peter Sutovsky of the University of 
Missouri, who was surprised to see his photo on a trading card. "It's a 
little overwhelming," said Sutovsky. "I wonder if I could find these in a 
card store. The question is how do you calculate a scientist's batting 
average?"

The promotions didn't stop with trading cards. The University of Chicago 
created a deck of playing cards decorated with protein images produced at 
Argonne National Laboratory, which it operates.

Such images provide invaluable information used to create new diagnostic 
and therapy tools for fighting diseases.

"We're using the playing cards to bring Argonne out of the closet," said 
Rosenberg. "Few people know that virtually every pharmaceutical company 
uses Argonne's Advanced Photon Source in their research."

Illinois and its card tricks were not lonely in the BIO2006 marketers' 
playground.

Early in the day chief executives from several biotech companies described 
how their firms use enzymes to turn corn and other plant products into 
plastics, fuel and fiber.

To illustrate their handiwork, after the executives stopped talking, music 
cranked up and models strutted back and forth on a runway wearing garments 
made from corn-based fiber. The models and their clothing were as 
attractive as anything staged at an upscale fashion show.

But perhaps the most ambitious marketing ploy at McCormick Place is the 
live corn field that has been transplanted into the convention hall. Along 
with the corn, companies promoting biotech seed brought farmers from around 
the world who grow biotech crops.

Advocate Mdutshane, a farmer from South Africa, plants about 25 acres of 
biotech sweet corn that he and his family eat themselves as well as sell.

"We want to tell people that this corn is safe for human consumption, and 
as a farmer I like the increase in yield," Mdutshane said. A month ago he 
visited a large meeting in Brazil to promote biotech crops.

Another South African at McCormick Place was Khosi Rebe, who grows biotech 
sweet corn as a farmer and who is also assistant director of a regional 
department of agriculture.

Sitting next to a corn field in a vast convention hall with thousands of 
people milling about, Rebe expressed some surprise at his situation.

He noted that delegates to the BIO trade show probably already appreciate 
the value of biotechnology.

Ordinary consumers aren't part of the event. "There are a lot of people who 
don't know much about this technology," Rebe said. "They could learn a lot 
if they were here."


================================
George Antunes, Political Science Dept
University of Houston; Houston, TX 77204
Voice: 713-743-3923  Fax: 713-743-3927
antunes at uh dot edu



Reply with a "Thank you" if you liked this post.
_____________________________

MEDIANEWS mailing list
[email protected]
To unsubscribe send an email to:
[EMAIL PROTECTED]

Reply via email to